FREND™ COVID-19 Ag is a third generation fluorescence immunoassay (FIA) for use with the FREND™ system.
FREND™ qualitative Covid-19 immunofluorescence antigen test
Qualitative Immunological Test in Microfluidics
FREND™ COVID-19 Ag
FREND™ COVID-19 Ag is a third generation fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein directly from nasopharyngeal swab samples in individuals suspected of being COVID-19 positive by their physician.
Accurate results in 3 minutes!
With only simple operational steps, the FREND ™ system supports a rapid diagnostic-decision-making process.
Evaluation of Test Performance
A total of 109 clinical samples (34 positive and 75 negative) confirmed by RT-PCR were tested with FREND™ COVID-19 Ag. The test showed 94.12% PPA (positive percentage match) and 100% NPA (negative percentage match) as shown below.
Effective data management
Laboratory Information System connectivity
(Laboratory Information System)
In the event of a pandemic, the management of a large amount of clinical results is important. However, many laboratories find it difficult to organise essential information effectively.
Works with FREND™ System Quantitative Immunoassay (not included)
The FREND™ rapid quantitative immunological analyser system is a small, fast and patient-friendly in vitro diagnostic system for quantitative measurement of biomarkers in samples.
The FREND ™ system, which is compatible with LIS, provides the following features: